SharonAI Holdings Inc. enters the back half of May carrying the clearest bearish positioning it has seen since listing — with short sellers doubling their exposure in a single week and a lock-up expiry four days away.
The pace of short-side accumulation here is the real story. Short Interest as a % of free float has nearly doubled in one week, climbing from roughly 4.2% to 8.5% of the free float — the highest level recorded since SHAZ went public. The monthly picture is even more striking: SI % FF was under 1% in early April and has expanded almost ninefold. That is an aggressive, deliberate build, not noise. The ORTEX short score has risen in lockstep, reaching 67.4 on May 14 after spending most of April in the mid-to-upper fifties. That score, in the upper third of the bearish range, reflects not just raw positioning but the velocity of the change.
The lending market confirms the pressure. Availability of shares to borrow — measured against current short interest — has tightened to 63%, meaning roughly one share remains available for every 1.6 already borrowed. That is well into the "tight" range. Availability was materially looser in April. Cost to borrow has been volatile, spiking to a recent high of 12.5% on May 11 before easing to 9.5% by May 14. The intra-week retreat in CTB is notable: it suggests some shorts covered or borrow was reshuffled after the Q1 print, but the overall borrow market remains far tighter than it was a month ago.
The backdrop driving that short build is a difficult Q1 result. SharonAI reported on May 15 after market close: revenue of $294,000 for the quarter, down from $325,000 a year earlier, with a net loss widening sharply to $19.9 million versus $1.4 million in Q1 2025. Full-year 2025 results told the same story — losses of $39.6 million against revenue of $1.6 million. The company is burning cash at a pace its top line cannot remotely support, and the stock's 56% one-month rally to $53.93 has pushed valuation to a point the fundamentals struggle to justify. The EV/EBITDA multiple, even as EBITDA is deeply negative, printed at 3.7x — down sharply from 4.6x a month ago — reflecting the swelling enterprise value against a loss-generating business.
The analyst picture is thin but directionally positive — three initiation calls since mid-April, all at Buy or Overweight, with price targets of $40–$50. Given the current price of $53.93, those targets imply the stock has already traded through the Street's near-term range; the mean target of $45 sits 16.6% below where shares closed on Friday. That is an unusual position to be in three weeks after coverage launched. These initiations predate the Q1 earnings miss, so the targets carry a stale-data caveat until the firms update.
Ownership adds one more variable to watch. A lock-up agreement covering officer and director options expires on May 20 — four days from now. Three individual holders together control roughly 25% of shares. All three reported new positions in the February–March window, suggesting they arrived at or near the IPO and are now inside a 90-day lock-up window approaching expiry. That does not guarantee selling, but it places a meaningful supply overhang on the immediate calendar.
The next confirmed earnings date is June 23. Between now and then, the lock-up expiry on May 20 and any updated analyst commentary following the Q1 miss are the most immediate watchpoints.
See the live data behind this article on ORTEX.
Open SHAZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
